2017 annual financial data
Alaunos Therapeutics 2017 Operating margin
Alaunos Therapeutics 2017 operating margin with verified reported values.
Direct answer
Operating margin was -837.27%.
Operating income was -53,493,000 USD and net income was -54,323,000 USD.
Operating cash flow was -54,669,000 USD.
Get free Alaunos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,389,000 USD
- Operating income
- -53,493,000 USD
- Net income
- -54,323,000 USD
- Operating cash flow
- -54,669,000 USD